Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes.

PLoS pathogens - 1 Jan 2013

Tavis John E, Cheng Xiaohong, Hu Yuan, Totten Michael, Cao Feng, Michailidis Eleftherios, Aurora Rajeev, Meyers Marvin J, Jacobsen E Jon, Parniak Michael A, Sarafianos Stefan G

Abstract excerpt

Nucleos(t)ide analog therapy blocks DNA synthesis by the hepatitis B virus (HBV) reverse transcriptase and can control the infection, but treatment is life-long and has high costs and unpredictable long-term side effects. The profound suppression of HBV by the nucleos(t)ide analogs and their ability to cure some patients indicates that they can push HBV to the brink of extinction. Consequently, more patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Design
Share to Drug Evaluation, Preclinical

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hepatitis B virus

Share to HIV Integrase Inhibitors

Share to In Vitro Techniques

Share to Molecular Targeted Therapy

Share to Viral Load

Share to Virus Replication

Source

Open in PubMed Open full text

Identifiers

PMID: 23349632
DOI: 10.1371/journal.ppat.1003125
PMCID: PMC3551811

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes.PMID 23349632Read ↗

Hepatitis B virus genetic diversity has minimal impact on sensitivity of the viral ribonuclease H to inhibitors.Semantic proximity Read ↗

Targeting the retroviral ribonuclease H by rational drug design.Semantic proximity Read ↗

Ultradeep pyrosequencing and molecular modeling identify key structural features of hepatitis B virus RNase H, a putative target for antiviral intervention.Semantic proximity Read ↗

Ribonuclease H: from discovery to 3D structure.Semantic proximity Read ↗

HIV-1 RT-Associated RNase H Function Inhibitors: Recent Advances in Drug DevelopmentSemantic proximity Read ↗

Quinolinonyl Non-Diketo Acid Derivatives as Inhibitors of HIV-1 Ribonuclease H and Polymerase Functions of Reverse Transcriptase.Semantic proximity Read ↗

Residues Arg703, Asp777, and Arg781 of the RNase H domain of hepatitis B virus polymerase are critical for viral DNA synthesis.Semantic proximity Read ↗

Characterization of a folding intermediate from HIV-1 ribonuclease H.Semantic proximity Read ↗

Efficacy of hepatitis B virus ribonuclease H inhibitors, a new class of replication antagonists, in FRG human liver chimeric mice.Semantic proximity Read ↗

Exploiting drug-resistant enzymes as tools to identify thienopyrimidinone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H.Semantic proximity Read ↗

Combinatorial Screening and Intracellular Antiviral Activity of Hairpin Ribozymes Directed against Hepatitis B VirusSemantic proximity Read ↗

Comparison of HBV ribonuclease H domain in naïve and drug resistant patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.